CD8A and endometrial cancer: The results showed that differences in methylation were more significant between the two groups of the CD8+ T cell activation model, indicating that the model can better reflect the heterogeneity among endometrial cancer patients and distinguish the origins of transcriptional pre-regulation that may influence differences in immune activity (Figures 4H, I).